Sana Biotechnology aims to raise $150M in IPO
January 13, 2021 at 16:35 PM EST
The Seattle-based gene therapy startup filed with the U.S. Securities and Exchange Commission on Wednesday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|